No abstract

Mushrooms have been used extensively in traditional medicine as antimicrobial, antiviral and antitumor agents. Infectious diseases remain a major threat to human health, due to global antimicrobial resistance. This has led to an increase in the search for new and potent antimicrobial substances. The aim of the present study was to investigate the antimicrobial activity of the aqueous (cold and hot) and organic solvents (methanol, ethanol and acetone) extracts of ten mushroom species collected from the woodlands in Zimbabwe against common local bacterial isolates Escherichia coli, Salmonella typhi, Staphylococcus aureus and Streptococcus pneumoniae using agar disc diffusion method. The crude extracts of the mushrooms exhibited antibacterial properties to all the bacteria tested. Extracts obtained from ethanol were the most effective tested against bacteria (36.5%), followed by methanol (30.8%) and acetone (30.8%). Aqueous extracts exhibited the lowest effect on bacterial growth inhibition (1.9%), despite including the extract with the highest inhibitory activity (14 mm). The acetone extract of Cantharellus symoensii had the second highest inhibitory value of 11.5 mm followed by the methanol extract from Cantharellus miomboensis and the ethanol extracts of Ganoderma lucidum and C.

No abstract

Mushrooms are known to possess a diversity of bioactive compounds that include lectins, which are proteins or glycoproteins that bind specifically to cell surface carbohydrates, culminating in cell agglutination. The present study describes the screening of lectin activity from ten local mushrooms, namely, Amanita zambiana, Boletus edulis, Cantharellus heinemannianus, Cantharellus miomboensis, Cantharellus symoensii, Lactarius kabansus, Amanita sp., Coprinus sp., Ganoderma lucidum and Trametes strumosa. The lectin content was detected by the haemagglutination activity of mushrooms against sheep and goat erythrocytes. Among the different mushrooms screened Amanita sp., Boletus edulis and Lactarius kabansus showed high lectin activity (39, 617 and 77 HAU/mg mushroom, respectively). Boletus edulis was used for the haemagglutination inhibition assay. A total of twenty sugars and sugar derivatives, namely, α-lactose, D-glucose, D-mannose, D-raffinose, N-acetyl glucosamine, maltose, melibiose, D-ribose, porcine mucin, D-cellobiose, D-arabinose, α-methyl-D-glucoside, methyl-α-D-mannopyranoside, D-trehalose, L-arabinose, L-sorbose, L-lyxose, β-lactose, DL-xylose, and D-galactose, were used for the haemagglutination inhibition assay. Of the various carbohydrates tested, only porcine mucin was found to be the most potent inhibitor of Boletus lectin. The lectin from Boletus mushroom was partially purified using ammonium sulphate precipitation. The highest lectin activity was observed in the 30%-60% fraction. This study revealed for the first time the occurrence of lectins in the local Zimbabwean mushrooms studied as well as isolation of a novel mucin-specific lectin. The information obtained can be used for further investigation of cell surface sugars, purification and characterisation of glycoproteins and their contribution towards the medicinal properties of local mushrooms.

The incidence of diseases is on the surge as exemplified by the recent occurrence in West Africa of Ebola Virus (EBOV) and increase of Zika Virus in Brazil. These pathogens have evolved strategies to evade the human immune system and thus continue to be globally important human pathogens. Bioengineering capabilities are on the increase with rapid advances in synthetic biology and allied technologies (nanobiotechnology, nanotechnology, OMICs technologies, and genetic engineering) which bring potential future prospects in combating disease causing agents using the knowledge of pathogenesis of these disease causing agents. This paper specifically takes a forward looking approach in proposing a potential future use of bioengineering technologies to combat disease causing pathogens as exemplified by Human Immunodeficiency Virus (HIV), Ebola Virus (EBOV), and Mycobacterium tuberculosis through the design, building and testing of synthetic bioengineered minimal genomes with pathogen neutralising capabilities and pathogen detection sensitivity similar to whole cell based biosensors.